Patent details

EP1666044 Title: Male contraceptive formulation comprising norethisterone

Basic Information

Publication number:
EP1666044
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP060753225
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Male contraceptive formulation comprising norethisterone
French Title of Invention:
Composition comprenant du noréthisterone pour la contraception masculine
German Title of Invention:
Zusammensetzung zur männlichen Kontrazeption, Norethisteron enthaltend
SPC Number:

Dates

Filing date:
15/02/2001
Grant date:
21/07/2010
EP Publication Date:
21/07/2010
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/06/2006
EP B1 Publication Date:
21/07/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/02/2011
Expiration date:
15/02/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/02/2001
 
 

Name:
Bayer Schering Pharma Aktiengesellschaft
Address:
Müllerstrasse 178, 13353 Berlin, Germany (DE)

Inventor

1

Name:
Schillinger Ekkerhard
Address:
Germany (DE)

2

Name:
Habenicht Ursula-Friederike
Address:
Germany (DE)

3

Name:
Rübig Alexander
Address:
Chile (CL)

4

Name:
Kamischke Axel
Address:
Germany (DE)

5

Name:
Oettel Michael
Address:
Germany (DE)

6

Name:
Nieschlag Eberhard
Address:
Germany (DE)

Priority

1

Priority Number:
503729
Priority Date:
15/02/2000
Priority Country:
United States (US)

2

Priority Number:
00200493
Priority Date:
15/02/2000
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 31/57;
Filing date Document type Number of pages